Business Context and Reporting Period
This Form 8-K Current Report was filed by AngioDynamics, Inc. on January 5, 2009. The filing discloses the execution of change in control severance agreements with four executive officers: Robert M. Rossell, Harold C. Mapes, David McDonald, and Sean Morris. These agreements were previously approved by the Compensation Committee and Board of Directors.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and executive compensation arrangements rather than financial performance results.
Material Changes and Agreements
- Severance Terms: The agreements have an initial term ending December 31, 2009, with automatic annual renewals. In the event of a change in control, the term extends to at least 12 months after the event.
- Change in Control Definition: Defined as a person acquiring >40% of voting securities, a majority board composition change, a merger/consolidation, or shareholder approval of liquidation/sale of assets.
- Severance Benefits: Upon qualifying termination following a change in control, executives receive:
- Two times their annual base salary.
- Unpaid and prorated annual bonus amounts.
- Compensation for earned but unused vacation time.
- Title to Company-owned or leased automobiles.
- Payment Structure: Payments are generally made in a lump sum within 30 days of termination, subject to Section 409A delays.
- Tax Considerations: Payments may be reduced to avoid Section 280G excise tax unless a gross-up would result in the executive receiving at least $50,000 more after taxes.
Outlook and Risks
The filing does not contain management commentary on future business outlook, general risks, or contingencies beyond the specific terms of the severance agreements. The Company intends to enter into similar agreements with future executive officers.
Investor Verification Checklist
- Verify the specific annual base salaries of the named executives to calculate potential severance liabilities.
- Review the full text of Exhibit 10.1 (Form of Severance Agreement) for detailed definitions of "cause," "good reason," and "disability."
- Assess the impact of these agreements on the Company's cash reserves in the event of a potential acquisition or change in control.
- Confirm if any other executives are covered under similar arrangements not listed in this specific filing.